azacitidine has been researched along with cysteine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bhagwat, AS; Gabbara, S; Wyszynski, MW | 1 |
| Hutchison, CA; Tollefsbol, TO | 1 |
1 review(s) available for azacitidine and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for azacitidine and cysteine
| Article | Year |
|---|---|
Substitutions of a cysteine conserved among DNA cytosine methylases result in a variety of phenotypes.
Topics: Azacitidine; Cloning, Molecular; Codon; Cysteine; DNA Mutational Analysis; DNA-Cytosine Methylases; Mutagenesis, Site-Directed; Recombinant Fusion Proteins | 1992 |
Analysis in Escherichia coli of the effects of in vivo CpG methylation catalyzed by the cloned murine maintenance methyltransferase.
Topics: Animals; Azacitidine; Binding Sites; Catalysis; Cloning, Molecular; Cysteine; DNA Methylation; DNA-Cytosine Methylases; DNA, Bacterial; Escherichia coli; Mice | 1998 |